Stemnion, Inc. is a privately held, biomedical company commercializing a proprietary cell-based technology platform to provide breakthrough regenerative medicine and cell transplantation therapies to treat human diseases and injuries such as wounds, neurotrauma, spinal cord injury and diabetes. Stemnion collaborates with major research centers to advance these therapeutic applications and has initiated clinical trials.